Continuing Effect of Cytokines and Toll-Like Receptor Agonists on Indoleamine-2,3-Dioxygenase-1 in Human Periodontal Ligament Stem/Stromal Cells

Continuing Effect of Cytokines and Toll-Like Receptor Agonists on Indoleamine-2,3-Dioxygenase-1 in Human Periodontal Ligament Stem/Stromal Cells

Transplanted mesenchymal stem/stromal cells (MSCs) are a promising and innovative approach in regenerative medicine. Their regenerative potential is partly based upon their immunomodulatory activities. One of the most investigated immunomediators in MSCs, such as in periodontal ligament-derived MSCs...

Full description

Bibliographic Details
Main Authors:	Christian Behm, Alice Blufstein, Johannes Gahn, Barbara Kubin, Andreas Moritz, Xiaohui Rausch-Fan, Oleh Andrukhov
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Cells
Subjects:	human periodontal ligament stromal cell immunomodulation indoleamine-2,3-dioxygenase-1 cytokines toll like receptor agonist
Online Access:	https://www.mdpi.com/2073-4409/9/12/2696

Similar Items

Indoleamine 2,3-dioxygenase in endometriosis
by: Hui-Li Yang, et al.
Published: (2019-01-01)

The Immunoregulatory Function of Indoleamine 2, 3 Dioxygenase and Its Application in Allotransplantation
by: Reza B. Jalili, et al.
Published: (2007-12-01)

Indoleamine 2,3-dioxygenase (IDO): Only an enzyme or a checkpoint controller?
by: Cemil Bilir, M.D., et al.
Published: (2017-07-01)

What is the prospect of indoleamine 2,3-dioxygenase 1 inhibition in cancer? Extrapolation from the past
by: Yu Yao, et al.
Published: (2021-02-01)

Contribution of indoleamine 2,3-dioxygenase in preeclampsia
by: Mona F.M El-Karn, et al.
Published: (2016-01-01)

Expression and Prognostic Value of Indoleamine 2,3-dioxygenase in Pancreatic Cancer
by: Tao Zhang, et al.
Published: (2017-01-01)

Cytokines Differently Define the Immunomodulation of Mesenchymal Stem Cells from the Periodontal Ligament
by: Christian Behm, et al.
Published: (2020-05-01)

TRYPTOPHAN AND INDOLEAMINE-2,3-DIOXYGENASE (IDO) IN PATHOGENESIS OF IMMUNOSUPPRESSIVE CLINICAL CONDITIONS
by: V. A. Kozlov, et al.
Published: (2017-07-01)

Effect of Indoleamine 2,3 Dioxygenase Inhibitor on the Cytotoxic Activity of Tumour-infiltrating Lymphocytes
by: Sarah Le Naour, et al.
Published: (2019-08-01)

Indoleamine 2,3-Dioxygenase 2 Immunohistochemical Expression in Resected Human Non-small Cell Lung Cancer: A Potential New Prognostic Tool
by: Martina Mandarano, et al.
Published: (2020-05-01)

Indoleamine 2,3-Dioxygenase Is Involved in Interferon Gamma’s Anti-BKPyV Activity in Renal Cells
by: Tony Fiore, et al.
Published: (2020-08-01)

The Relationships among Tryptophan, Kynurenine, Indoleamine 2,3-Dioxygenase, Depression, and Neuropsychological Performance
by: Knut A. Hestad, et al.
Published: (2017-10-01)

The Role of Indoleamine 2, 3-Dioxygenase in Immune Suppression and Autoimmunity
by: Jacques C. Mbongue, et al.
Published: (2015-09-01)

Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now?
by: Andrew L. Mellor, et al.
Published: (2017-10-01)

The 14kDa Protein Molecule Isolated from Garlic Suppresses Indoleamine 2, 3-Dioxygenase Metabolites in Mononuclear Cells In vitro
by: Nikoo Shohreh, et al.
Published: (2008-12-01)

The role of eosinophils in the neonatal murine thymus; Expression of Indoleamine 2,3-dioxygenase
by: Cravetchi, Olga Vladimir
Published: (2009)

Neopterin suppresses the activity of tryptophan-degrading enzyme indoleamine 2,3-dioxygenase in human peripheral blood mononuclear cells
by: Schroecksnadel Sebastian, et al.
Published: (2013-12-01)

Association between endometrial indoleamine 2,3-dioxygenase expression level and pregnancy outcomes in women undergoing first in vitro fertilization treatment
by: Su Liu, et al.
Published: (2021-01-01)

Highly Efficient Stable Expression of Indoleamine 2,3 Dioxygenase Gene in Primary Fibroblasts
by: Ong Christopher, et al.
Published: (2010-01-01)

Highly Efficient Stable Expression of Indoleamine 2,3 Dioxygenase Gene in Primary Fibroblasts
by: Rezakhanlou Alireza, et al.
Published: (2010-03-01)

Rôle de l'indoléamine-2,3-dioxygénase dans la persistance des infections virales
by: Lepiller, Quentin
Published: (2015)

What May Constrain the Success of Indoleamine 2,3-Dioxygenase 1 Inhibitors in Cancer Immunotherapy?
by: Theodoros Eleftheriadis
Published: (2018-08-01)

The Role of Indoleamine-2,3-Dioxygenase in Cancer Development, Diagnostics, and Therapy
by: Lilla Hornyák, et al.
Published: (2018-01-01)

Indoleamine-2,3-Dioxygenase Mediates Emotional Deficits by the Kynurenine/Tryptophan Pathway in the Ethanol Addiction/Withdrawal Mouse Model
by: Xi Jiang, et al.
Published: (2020-02-01)

Indoleamine 2, 3-dioxygenase inhibitors in immunochemotherapy of breast cancer: challenges and opportunities
by: Nastran Hashemzadeh, et al.
Published: (2019-01-01)

Indoleamine 2,3 dioxygenase (IDO) level as a marker for significant coronary artery disease
by: Nattawut Wongpraparut, et al.
Published: (2021-07-01)

Indoleamine 2,3-dioxygenase expression and overall survival in patients diagnosed with breast cancer in Pakistan
by: Asghar K, et al.
Published: (2019-01-01)

Indoleamine 2,3-Dioxygenase Expression Pattern in the Tumor Microenvironment Predicts Clinical Outcome in Early Stage Cervical Cancer
by: A. Marijne Heeren, et al.
Published: (2018-07-01)

Design and Synthesis of Indoleamine 2,3-Dioxygenase 1 Inhibitors and Evaluation of Their Use as Anti-Tumor Agents
by: Hui Wen, et al.
Published: (2019-06-01)

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors
by: Zulfiqar B, et al.
Published: (2017-01-01)

Investigating the Role of Indoleamine 2,3-Dioxygenase in Acute Myeloid Leukemia: A Systematic Review
by: Georgia Wells, et al.
Published: (2021-03-01)

Expression of indoleamine 2,3-dioxygenase in a murine model of Aspergillus fumigatus keratitis
by: Nan Jiang, et al.
Published: (2016-04-01)

Depression and anxiety in patients with multiple sclerosis treated with interferon-beta or fingolimod: Role of indoleamine 2,3-dioxygenase and pro-inflammatory cytokines
by: Carlos B. Tauil, et al.
Published: (2020-12-01)

Suppression of indoleamine-2,3-dioxygenase 1 expression by promoter hypermethylation in ER-positive breast cancer
by: Dyah L. Dewi, et al.
Published: (2017-02-01)

Reliable chromatographic assay for measuring of indoleamine 2,3-dioxygenase 1 (IDO1) activity in human cancer cells
by: Ilona Sadok, et al.
Published: (2021-01-01)

Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression
by: Irina Banzola, et al.
Published: (2018-05-01)

Local Inhibition of Indoleamine 2,3-Dioxygenase Mitigates Renal Fibrosis
by: Camilla Grønkjær Jensen, et al.
Published: (2021-07-01)

Deletion of indoleamine 2,3 dioxygenase (Ido)1 but not Ido2 exacerbates disease symptoms of MOG35-55-induced experimental autoimmune encephalomyelitis
by: Lisa A. Wetzel, et al.
Published: (2020-08-01)

Inhibitory effects of flavonoids isolated from Sophora flavescens on indoleamine 2,3-dioxygenase 1 activity
by: Mincheol Kwon, et al.
Published: (2019-01-01)

Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0
by: Yvonne Grobben, et al.
Published: (2021-01-01)